La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
ICU Medical Croissance future
Future contrôle des critères 3/6
ICU Medical devrait augmenter ses bénéfices et son chiffre d'affaires de 64.7% et de 3% par an respectivement. Le BPA devrait croître de de 65.8% par an. Le rendement des capitaux propres devrait être 5.1% dans 3 ans.
Informations clés
64.7%
Taux de croissance des bénéfices
65.8%
Taux de croissance du BPA
Medical Equipment croissance des bénéfices | 17.4% |
Taux de croissance des recettes | 3.0% |
Rendement futur des capitaux propres | 5.1% |
Couverture par les analystes | Good |
Dernière mise à jour | 04 Sep 2024 |
Mises à jour récentes de la croissance future
Recent updates
ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry
Aug 18ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly
Aug 07ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult
Jun 27ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price
Jun 23Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package
May 09Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S
Apr 26ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Mar 31Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?
Jan 31ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business
Jan 04These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively
Oct 28Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?
Oct 07ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Jul 19Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Jun 22Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt
Apr 03Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Feb 27ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Dec 07ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Sep 07ICU Medical Hit Hard As Smiths Medical Needs Significant TLC
Aug 20ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M
Aug 08FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious
Jul 20ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Jun 08ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value
Mar 25A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Feb 23Analysts Just Made A Significant Upgrade To Their ICU Medical, Inc. (NASDAQ:ICUI) Forecasts
Jan 28Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 2,482 | 67 | 188 | 271 | 2 |
12/31/2025 | 2,408 | 34 | 168 | 265 | 6 |
12/31/2024 | 2,318 | -80 | 113 | 169 | 6 |
6/30/2024 | 2,304 | -71 | 157 | 254 | N/A |
3/31/2024 | 2,257 | -59 | 75 | 171 | N/A |
12/31/2023 | 2,259 | -30 | 73 | 166 | N/A |
9/30/2023 | 2,249 | -28 | -13 | 73 | N/A |
6/30/2023 | 2,294 | -48 | -44 | 40 | N/A |
3/31/2023 | 2,306 | -46 | -110 | -20 | N/A |
12/31/2022 | 2,280 | -74 | -161 | -62 | N/A |
9/30/2022 | 2,043 | -39 | -78 | 22 | N/A |
6/30/2022 | 1,781 | 5 | -1 | 99 | N/A |
3/31/2022 | 1,541 | 41 | 124 | 215 | N/A |
12/31/2021 | 1,316 | 103 | 186 | 268 | N/A |
9/30/2021 | 1,296 | 109 | 175 | 263 | N/A |
6/30/2021 | 1,279 | 103 | 168 | 260 | N/A |
3/31/2021 | 1,260 | 94 | 146 | 235 | N/A |
12/31/2020 | 1,271 | 87 | 122 | 223 | N/A |
9/30/2020 | 1,266 | 81 | 98 | 193 | N/A |
6/30/2020 | 1,255 | 83 | 73 | 168 | N/A |
3/31/2020 | 1,264 | 87 | 60 | 162 | N/A |
12/31/2019 | 1,266 | 101 | -4 | 102 | N/A |
9/30/2019 | 1,291 | 73 | 3 | 103 | N/A |
6/30/2019 | 1,311 | 47 | 1 | 104 | N/A |
3/31/2019 | 1,359 | 55 | 57 | 160 | N/A |
12/31/2018 | 1,400 | 29 | 59 | 160 | N/A |
9/30/2018 | 1,430 | 86 | 90 | 195 | N/A |
6/30/2018 | 1,446 | 86 | 140 | 242 | N/A |
3/31/2018 | 1,417 | 18 | N/A | 210 | N/A |
12/31/2017 | 1,293 | 69 | N/A | 154 | N/A |
9/30/2017 | 1,018 | 28 | N/A | 91 | N/A |
6/30/2017 | 772 | 47 | N/A | 19 | N/A |
3/31/2017 | 537 | 101 | N/A | -4 | N/A |
12/31/2016 | 379 | 63 | N/A | 90 | N/A |
9/30/2016 | 372 | 59 | N/A | 84 | N/A |
6/30/2016 | 361 | 56 | N/A | 77 | N/A |
3/31/2016 | 348 | 53 | N/A | 68 | N/A |
12/31/2015 | 340 | 45 | N/A | 64 | N/A |
9/30/2015 | 329 | 47 | N/A | 61 | N/A |
6/30/2015 | 321 | 37 | N/A | 61 | N/A |
3/31/2015 | 316 | 29 | N/A | 61 | N/A |
12/31/2014 | 307 | 26 | N/A | 66 | N/A |
9/30/2014 | 306 | 32 | N/A | 72 | N/A |
6/30/2014 | 311 | 37 | N/A | 69 | N/A |
3/31/2014 | 311 | 38 | N/A | 68 | N/A |
12/31/2013 | 312 | 40 | N/A | 66 | N/A |
9/30/2013 | 318 | 39 | N/A | 68 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: ICUI devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 2.5% ).
Bénéfices vs marché: ICUI devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.
Croissance élevée des bénéfices: ICUI devrait devenir rentable dans les 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de ICUI ( 3% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).
Croissance élevée des revenus: Le chiffre d'affaires de ICUI ( 3% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de ICUI devrait être faible dans 3 ans ( 5.1 %).